Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir

Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir

Children with high-risk SHH/<i>TP53</i>-mut and Group 3 medulloblastoma (MB) have a 5-year overall survival of only 40%. Innovative approaches to enhance survival while preventing adverse effects are urgently needed. We investigated an innovative therapy approach combining irradiation (R...

Full description

Bibliographic Details
Main Authors:	Marieke Gringmuth, Jenny Walther, Sebastian Greiser, Magali Toussaint, Benjamin Schwalm, Marcel Kool, Rolf-Dieter Kortmann, Annegret Glasow, Ina Patties
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	International Journal of Molecular Sciences
Subjects:	medulloblastoma radiation decitabine abacavir in vivo study magnetic resonance imaging
Online Access:	https://www.mdpi.com/1422-0067/23/7/3815

Similar Items

The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
by: Ina Patties, et al.
Published: (2019-10-01)

Radiotherapy in Medulloblastoma—Evolution of Treatment, Current Concepts and Future Perspectives
by: Clemens Seidel, et al.
Published: (2021-11-01)

Severe abacavir hypersensitivity reaction in a patient with human immunodeficiency virus infection: a case report
by: Mathew K. Koech, et al.
Published: (2022-11-01)

Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
by: Saye H. Khoo, et al.
Published: (2011-06-01)

Abacavir use is associated with increased prothrombin conversion
by: Qiuting Yan, et al.
Published: (2023-04-01)

Evaluation of cardiovascular biomarkers In HIV-infected patients switching to abacavir or tenofovir based therapy
by: Langdahl Bente L, et al.
Published: (2011-10-01)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Ho, Sharlene, et al.
Published: (2021)

Estimated use of abacavir among adults and children enrolled in public sector antiretroviral therapy programmes in Gauteng, South Africa
by: D Evans, et al.
Published: (2012-08-01)

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany
by: Wolf E, et al.
Published: (2010-04-01)

AOP-Based Transformation of Abacavir in Different Environments: Evolution Profile of Descyclopropyl-Abacavir and In Silico Toxicity Assessment of the Main Transformation Products
by: Eleni Evgenidou, et al.
Published: (2023-02-01)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Sharlene Ho, et al.
Published: (2020-05-01)

Medulloblastoma – an overview
by: A. V. Ciurea, et al.
Published: (2010-09-01)

Bioequivalence study of abacavir/lamivudine (600/300-mg) tablets in healthy Thai volunteers under fasting conditions
by: Ekawan Yoosakul, et al.
Published: (2016-02-01)

In-vivo proton range verification for reducing the risk of permanent alopecia in medulloblastoma treatment
by: Giulia Lucconi, et al.
Published: (2021-09-01)

Comparison of Chemical and Electrochemical Approaches to Abacavir Oxidative Stability Testing
by: Lucie Pražáková, et al.
Published: (2023-03-01)

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma
by: Lien Provez, et al.
Published: (2023-01-01)

Is adult medulloblastoma merely the counterpart of pediatric medulloblastoma?
by: Gabriel Chun-Hei Wong, et al.
Published: (2020-01-01)

Comparison of electrochemical and chemical approaches to forced oxidative degradation studies: Abacavir case study
by: Filip Vymyslický, et al.
Published: (2024-01-01)

Gene Expression Profiles Identify Biomarkers of Resistance to Decitabine in Myelodysplastic Syndromes
by: Seungyoun Kim, et al.
Published: (2021-12-01)

Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
by: Z. C. Lim, et al.
Published: (2021-11-01)

Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire
by: Patricia T. Illing, et al.
Published: (2021-05-01)

Hairpin-bisulfite sequencing of cells exposed to decitabine documents the process of DNA demethylation
by: Issam M Mayyas, et al.
Published: (2021-11-01)

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
by: Bagella P, et al.
Published: (2019-05-01)

Proteomic Profiling and T Cell Receptor Usage of Abacavir Susceptible Subjects
by: Eline Gall, et al.
Published: (2022-03-01)

Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro
by: Friederike Rothe, et al.
Published: (2022-05-01)

Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study
by: Kunchok Dorjee, et al.
Published: (2017-10-01)

MEDULLOBLASTOMA – CLINICAL AND THERAPEUTICAL ASPECTS
by: Catalin Prazaru, et al.
Published: (2017-06-01)

Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
by: Teshale Ayele Mega, et al.
Published: (2020-03-01)

Unravelling the Proteomics of HLA-B*57:01<sup>+</sup> Antigen Presenting Cells during Abacavir Medication
by: Funmilola Josephine Haukamp, et al.
Published: (2022-01-01)

Acute appendicitis in acute leukemia and the potential role of decitabine in the critically ill patient
by: Deepti Warad, et al.
Published: (2015-01-01)

A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects
by: Ji Xiao, et al.
Published: (2022-03-01)

Therapeutic effect of folic acid combined with decitabine on diabetic mice
by: Gang Du, et al.
Published: (2023-11-01)

Extraneural metastases in medulloblastoma
by: V M F Muoio, et al.
Published: (2011-01-01)

Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma
by: Timothy Budden, et al.
Published: (2018-01-01)

Adult medulloblastoma
by: S. V. Rege, et al.
Published: (2016-12-01)

Dynamic profiling of medulloblastoma surfaceome
by: David Bakhshinyan, et al.
Published: (2023-07-01)

Rare cases of medulloblastoma with hypermutation
by: Aditi Bagchi, et al.
Published: (2022-05-01)

The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection
by: A V Kravchenko, et al.
Published: (2014-11-01)

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study
by: Karam Mounzer, et al.
Published: (2019-01-01)

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
by: Briot T, et al.
Published: (2017-11-01)